What question did this study set out to answer?

This research aims to compare the effectiveness of intranasal corticosteroids and antihistamines in improving quality of life in children with allergic rhinoconjunctivitis.

June 5, 2026Open Access

Comparative Efficacy of Intranasal Corticosteroids and Antihistamines in Enhancing Paediatric Quality of Life in Allergic Rhinoconjunctivitis

Key Points

This research aims to compare the effectiveness of intranasal corticosteroids and antihistamines in improving quality of life in children with allergic rhinoconjunctivitis.
Daily administration of intranasal corticosteroids and antihistamines was evaluated in different age groups.
Participants included adolescents aged 12–18 years and children aged 6–11 years.
Quality of life assessments were conducted post-treatment.
Intranasal corticosteroids significantly improved quality of life in adolescents compared to antihistamines.
Antihistamines provided greater quality of life enhancement in younger children than intranasal corticosteroids.

Abstract

Summary Daily intranasal corticosteroids improved quality of life most in adolescents (12–18 years) with seasonal allergic rhinoconjunctivitis. Antihistamines showed greater quality‐of‐life improvement than intranasal corticosteroids in children (6–11 years).

Read Full Paperexternally

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Tameeris et al. (Wed,) studied this question.

synapsesocial.com/papers/6a2268f9763171746d54781d https://doi.org/https://doi.org/10.1111/cea.70360

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Perguntar à IA

Bookmark

View Full Paper